Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06033729Not ApplicableCompleted

Remifentanil Target Controlled Infusion Versus Standard of Care for Conscious Sedation During EBUS-TBNA

Role: lead

NCT05001529Phase 4Unknown

Flow Cytometry Analysis of Eosinophils in Severe Asthma Patients.

Role: lead

NCT02809872Unknown

Ultrasound Estimation of Pleural Effusion in the Sitting Patients

Role: lead

NCT02801058Not ApplicableCompleted

Ultrasound Evaluation of Changes in Diaphragm Induced by Osteopathic Manipulative Techniques

Role: lead

All 4 trials loaded